Dhar, S. S., Brown, C., Rizvi, A., Reed, L., Kotla, S., Zod, C., . . . Lee, M. G. (2025). Heterozygous Kmt2d loss diminishes enhancers to render medulloblastoma cells vulnerable to combinatory inhibition of LSD1 and OXPHOS. Cell Reports, 44(5), . https://doi.org/10.1016/j.celrep.2025.115619
Chicago-referens (17:e uppl.)Dhar, Shilpa S., et al. "Heterozygous Kmt2d Loss Diminishes Enhancers to Render Medulloblastoma Cells Vulnerable to Combinatory Inhibition of LSD1 and OXPHOS." Cell Reports 44, no. 5 (2025). https://doi.org/10.1016/j.celrep.2025.115619.
MLA-referens (9:e uppl.)Dhar, Shilpa S., et al. "Heterozygous Kmt2d Loss Diminishes Enhancers to Render Medulloblastoma Cells Vulnerable to Combinatory Inhibition of LSD1 and OXPHOS." Cell Reports, vol. 44, no. 5, 2025, https://doi.org/10.1016/j.celrep.2025.115619.
